Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de pointes in models of acquired and congenital long QT syndrome
W. Shimizu et al., Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de pointes in models of acquired and congenital long QT syndrome, J CARD ELEC, 10(2), 1999, pp. 154-164
Citations number
37
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Electrophysiologic Effects of Pentobarbital, Introduction: Sodium pentobarb
ital is widely used for anesthesia in experimental studies as well as in cl
inics, and it is known to prevent the development of torsades de pointes (T
dP) in in vivo models of the long QT syndrome (LQTS).
Methods and Results: This study examines the effects of pentobarbital on tr
ansmural dispersion of repolarization (TDR) and induction of TdP in arteria
lly perfused canine left ventricular wedge preparations in which transmembr
ane action potentials were simultaneously recorded from epicardial, M, and
endocardial regions using floating glass microelectrodes together with a tr
ansmural EGG. d-Sotalol and ATX-II were used to mimic the LQT2 and LQT3 for
ms of congenital LOTS. Both d-sotalol (100 mu mol/L, n = 6) and ATX-II (20
nmol/L, n = 6) preferentially prolonged the action potential duration (APD(
90)) of the M cell, thus increasing in the QT interval and TDR, and leading
to the development of spontaneous and stimulation-induced TdP. In the abse
nce and presence of d-sotalol, pentobarbital (10, 20, and 50 mu g/mL) prolo
nged the APD(90) of epicardial and endocardial cells, and, to a lesser exte
nt, that of the M cell, thus prolonging the QT interval but reducing TDR. I
n the ATX-II model, the effects of pentobarbital on the QT interval and APD
(90) were biphasic: 10 mu g/mL pentobarbital further prolonged APD(90) of e
picardial and endocardial cells more than that of the M cell; 20 to 50 mu g
/mL pentobarbital abbreviated the APD(90) of epicardial and endocardial cel
ls less than that of the M cell, thus abbreviating the QT interval and mark
edly reducing TDR. Twenty to 50 mu g/mL pentobarbital totally suppressed sp
ontaneous as well as stimulation-induced TdP in both models.
Conclusion: Our data indicate that pentobarbital reduces TDR in control and
under conditions of congenital and acquired LOTS, and suggest that this me
chanism may contribute to the ability of the anesthetic to prevent the deve
lopment of spontaneous as well as stimulation-induced TdP under conditions
mimicking LQT2, LQT3, and acquired (drug-induced) forms of the LOTS. The da
ta also serve to illustrate that there are circumstances under which QT pro
longation may not be arrhythmogenic.